RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...
Management raised the 2025 revenue outlook to $10.7 billion, reflecting 11% growth, and adjusted EPS is anticipated at $4.75, representing 22% growth. Non-GAAP operating margin is projected at 6.9%.
Celestica shares fell in lockstep with other tech companies Monday as China's DeepSeek low-cost AI model rattled the sector. Shares trading in Toronto were down nearly 17% to 144.23 Canadian dollars.